Status:
COMPLETED
HKT-500-US12 In Adult Patients With OA Knee Pain
Lead Sponsor:
Hisamitsu Pharmaceutical Co., Inc.
Conditions:
Osteoarthritis, Knee
Eligibility:
All Genders
45+ years
Phase:
PHASE2
Brief Summary
The objective of this study is to characterize the analgesic properties of single dose study of HKT-500 in subjects with pain caused by mild to moderate OA of the knee
Detailed Description
A Randomized, Multicenter, Double-Blind, Single Dose Study of the Analgesic Properties of HKT-500 and Placebo in Subjects with Pain Caused by Mild to Moderate Osteoarthritis of the Knee
Eligibility Criteria
Inclusion
- male or female 45 years of age or older
- with osteoarthritis of the knee
Exclusion
- subject is a woman of childbearing potential
- who has a positive urine pregnancy test,
- is lactating, or who is not surgically sterile
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00647231
Start Date
March 1 2008
End Date
August 1 2008
Last Update
June 4 2015
Active Locations (29)
Enter a location and click search to find clinical trials sorted by distance.
1
Hisamitsu Investigator Site
Birmingham, Alabama, United States, 35209
2
Hisamitsu Investigator Site
Phoenix, Arizona, United States, 85013
3
Hisamitsu Investigator Site
Little Rock, Arkansas, United States, 72205
4
Hisamitsu Investigator Site
Little Rock, Arkansas, United States, 72211